Novel shRNA molecules and methods of use thereof
AssigneeGradalis, Inc.
InventorDonald Rao
Life of this patent
Estimating the term…
Loading patent…
AssigneeGradalis, Inc.
InventorDonald Rao
Estimating the term…
The present invention relates to certain novel shRNA molecules and methods of use thereof. According to certain embodiments of the present invention, methods for reducing the expression level of a target gene are provided. Such methods generally comprise providing a cell with one or more precursor nucleic acid sequences that encode two or more RNA molecules. A first RNA molecule comprises a double stranded sequence, which includes a guide strand sequence that is complementary to a portion of an mRNA transcript encoded by the target gene. In addition, a second RNA molecule comprises a second double stranded sequence, which includes a second guide strand sequence that is partially complementary to a portion of the mRNA transcript encoded by the target gene. Preferably, the second guide strand sequence comprises one or more bases that are mismatched with a nucleic acid sequence of the mRNA transcript encoded by the target gene.
A method for reducing the expression level of a target gene, which comprises providing a cell with one or more precursor nucleic acid sequences that encode two or more RNA molecules, wherein:
A method for reducing the expression level of a target gene, which comprises providing a cell with one or more precursor nucleic acid sequences that encode two or more RNA molecules, wherein:
A nucleic acid sequence, which may comprise a single contiguous sequence or multiple distinct sequences that, individually or collectively, encode two or more RNA molecules, wherein:
A nucleic acid sequence, which may comprise a single contiguous sequence or multiple distinct sequences that, individually or collectively, encode two or more RNA molecules, wherein:
Dependencies are inferred from the claim text.